Ödem
Özet
Ödem, interstisyel alanda serbest sıvı miktarının artmasıyla oluşan ve kalp yetmezliği, siroz veya nefrotik sendrom gibi sistemik hastalıkların yanı sıra lokal faktörlere de bağlı gelişebilen bir klinik durumdur. Patofizyolojisi temel olarak Starling kuvvetlerindeki dengesizliklere ve böbreklerin sodyum ile su tutulumuna dayanırken, tanı sürecinde ödemin dağılımı, gode bırakma özelliği ve eşlik eden semptomlar ayırıcı tanı için kritik önem taşır. Tedavi yaklaşımı, altta yatan nedene yönelik olarak sıvı ve tuz kısıtlamasının yanı sıra diüretik kullanımını ve yaşam tarzı değişikliklerini kapsayan kişiselleştirilmiş bir strateji gerektirir.
Edema is a clinical condition characterized by an increase in free fluid within the interstitial space, arising from systemic diseases such as heart failure, cirrhosis, or nephrotic syndrome, as well as local factors. Its pathophysiology is primarily based on imbalances in Starling forces and renal sodium and water retention, while the distribution, pitting characteristics, and accompanying symptoms are critical for differential diagnosis. The treatment approach requires a personalized strategy involving fluid and salt restriction, the use of diuretics tailored to the underlying cause, and lifestyle modifications.
Referanslar
Braunwald, Eugene, and Joseph Loscalzo. "Chapter 37: Edema. Harrison's Principles of Internal Medicine, 20e Eds. J. Larry Jameson, et al. McGraw Hill, 2018
Guyton, A. C. "Chapter 16: The microcirculation and the lymphatic system: capillary fluid exchange, interstitial fluid, and lymph flow." Textbook of medical physiology. 8th ed. Philadelphia: WB Saunders (1990): 170.
Elhassan EA, Schrier RW, Disorder of extracellular Volume. In. Comprehensive Clinical Nephrology, 4th ed (Eds J Floege, RJ Johnson, J Feehally):85-99. St Louis, Missouri, Elsevier, 2010.
Sterns, Richard H. ve Lisa Kunins. "Yetişkinlerde ödem patofizyolojisi ve etiyolojisi." Güncel. Waltham, MA: Bugüne Kadar (2013)
Schrier RW, Abraham WT. Hormones and hemodynamics in heart failure. N Engl J Med. 1999;341:577-85.
Ginès P, Fernández-Esparrach G, Arroyo V, Rodés J. Pathogenesis of ascites in cirrhosis. Semin Liver Dis. 1997;17:175-89
Rodríguez-Iturbe B, Herrera-Acosta J, Johnson RJ. Interstitial inflammation, sodium retention, and the pathogenesis of nephrotic edema: a unifying hypothesis. Kidney Int. 2002;62:1379-84.
Messerli FH. Vasodilatory edema: a common side effect of antihypertensive therapy. Curr Cardiol Rep. 2002;4:479-82.
Noll G, Lüscher TF. Comparative pharmacological properties among calcium channel blockers: Tchannel versus L-channel blockade. Cardiology. 1998;89:10-5.
Guan Y, Hao C, Cha DR, Rao R, Lu W, Kohan DEet al. Thiazolidinediones expand body fluid volume through PPARgamma stimulation of ENaC-mediated renal salt absorption. Nat Med. 2005;11:861-6.
Streeten DH. Idiopathic edema: pathogenesis, clinical features, and treatment. Endocrinol Metab Clin North Am. 1995;24:531-47.
Streeten DH. Idiopathic edema. Curr Ther Endocrinol Metab. 1997;6:203-6.
Musielak, Matthew C., and Jung Hee Chae. "Hypothyroid-induced acute compartment syndrome in all extremities." Journal of Surgical Case Reports 2016.12 (2016): rjw215.
Blankfield RP, Finkelhor RS, Alexander JJ, Flocke SA, Maiocco J, Goodwin M, et al. Etiology and diagnosis of bilateral leg edema in primary care. Am J Med. 1998;105:192-7.
Aştı TA, Karadağ A. (2011). Klinik Uygulama Becerileri ve Yöntemleri, Nobel Kitabevi, s. 592- 593
Padberg F Jr, Cerveira JJ, Lal BK, Pappas PJ, Varma S, Hobson RW 2nd. Does severe venous insufficiency have a different etiology in the morbidly obese? is it venous? J Vasc Surg. 2003;37:79-85.
Buggey J, Mentz RJ, Pitt B, Eisenstein EL, Anstrom KJ, Velazquez EJ, et al. A reappraisal of loop diuretic choice in heart failure patients. Am Heart J.2015;169:323-33.
De Vecchis R, Ciccarelli A, Ariano C, Cioppa C, Giasi A, Pucciarelli A et al. In chronic heart failure with marked fluid retention, the i.v.high doses of loop diuretic are a predictor of aggravated renal dysfunction,especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function. Minerva Cardioangiol. 2011;59:543-54.
Sica DA, Carter B, Cushman W, Hamm L. Thiazide and loop diuretics. J Clin Hypertens. 2011;13:639-43.
Udelson, James E et al. “A multicenter, randomized, double-blind, placebo-controlled study of tolvaptan monotherapy compared to furosemide and the combination of tolvaptan and furosemide in patients with heart failure and systolic dysfunction.” Journal of cardiac failure vol. 17,12 (2011): 973-81. doi:10.1016/j.cardfail.2011.08.005
Takada, Tesshu et al. “Tolvaptan alleviates excessive fluid retention of nephrotic diabetic renal failure unresponsive to furosemide.” Nephrology (Carlton, Vic.) vol. 23,9 (2018): 883-886. doi:10.1111/nep.13390
Saimiya, Mari et al. “Efficacy of oral tolvaptan for severe edema and hyponatremia in a patient with refractory nephrotic syndrome.” CEN case reports vol. 10,4 (2021): 523-526. doi:10.1007/s13730-021-00601-1
